Expression profile and clinical significance of MicroRNAs in papillary thyroid carcinoma

Molecules

Volumn 19, Issue 8, 2014, Pages 11586-11599

  Peng, You ^a   Li, Chen ^b   Luo, Ding Cun ^c   Ding, Jin Wang ^a   Zhang, Wo ^a   Pan, Gang ^a  

^a HANGZHOU FIRST PEOPLE'S HOSPITAL   (China)

^b WUXI NO 2 PEOPLE S HOSPITAL   (China)

^c ZHEJIANG CANCER HOSPITAL   (China)

Author keywords

Invasiveness; MiRNA; Papillary thyroid carcinoma

Indexed keywords

MICRORNA; TRANSCRIPTOME;

ADULT; CANCER STAGING; CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENETICS; GOITER, NODULAR; HUMAN; LYMPH NODE METASTASIS; MALE; MIDDLE AGED; PROGNOSIS; REPRODUCIBILITY; THYROID NEOPLASMS; TUMOR VOLUME;

ADULT; CARCINOMA; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; GOITER, NODULAR; HUMANS; LYMPHATIC METASTASIS; MALE; MICRORNAS; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; REPRODUCIBILITY OF RESULTS; THYROID NEOPLASMS; TRANSCRIPTOME; TUMOR BURDEN;

EID: 84906713399     PISSN: None     EISSN: 14203049     Source Type: Journal    
DOI: 10.3390/molecules190811586     Document Type: Article

References (40)

1. Jemal, A.; Siegel, R.; Xu, J.; Ward, E. Cancer statistics. CA Cancer J. Clin. 2010, 60, 277-300.
2. Ferlay, J.; Steliarova-Foucher, E.; Lortet-Tieulent, J.; Rosso, S.; Coebergh, J.W.; Comber, H.; Forman, D.; Bray, F. Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012. Eur. J. Cancer 2013, 49, 1374-1403.
3. Cooper, D.S.; Doherty, G.M.; Haugen, B.R.; Kloos, R.T.; Lee, S.L.; Mandel, S.J.; Mazzaferri, E.L.; McIver, B.; Pacini, F.; Schlumberger, M.; et al. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association (ATA) Guidelines Taskforce on Thyroid Nodules and Differentiated Thyroid Cancer. Thyroid 2009, 19, 1167-1214.
4. Loh, K.C.; Greenspan, F.S.; Gee, L.; Miller, T.R.; Yeo, P.P. Pathological tumor-node-metastasis (pTNM) staging for papillary and follicular thyroid carcinomas: A retrospective analysis of 700 patients. J. Clin. Endocrinol. MeTable 1997, 82, 3553-3562.
5. Syrenicz, A.; Koziołek, M.; Ciechanowicz, A.; Sieradzka, A.; Bińczak-Kuleta, A.; Parczewski, M. New insights into the diagnosis of nodular goiter. Thyroid Res. 2014, 7, doi:10.1186/1756-6614-7-6.
6. Brito, J.P.; Hay, I.D.; Morris, J.C. Low risk papillary thyroid cancer. BMJ 2014, 348, doi:http://dx.doi.org/10.1136/bmj.g3045.
7. Tufano, R.P.; Teixeira, G.V.; Bishop, J.; Carson, K.A.; Xing, M. BRAF mutation in papillary thyroid cancer and its value in tailoring initial treatment: A systematic review and meta-analysis. Medicine (Baltimore) 2012, 91, 274-286.
8. Jazdzewski, K.; Liyanarachchi, S.; Swierniak, M.; Pachucki, J.; Ringel, M.D.; Jarzab, B.; de la Chapelle, A. Polymorphic mature microRNAs from passenger strand of pre-miR-146a contribute to thyroid cancer. Proc. Natl. Acad. Sci. USA 2009, 106, 1502-1505.
9. Lodewijk, L.; Prins, A.M.; Kist, J.W.; Valk, G.D.; Kranenburg, O.; Rinkes, I.H.; Vriens, M.R. The value of miRNA in diagnosing thyroid cancer: A systematic review. Cancer Biomark. 2012, 11, 229-238.
10. Giulia, C.; Pierfrancesco, F.; Loredana, P.; Salvatore, P.; Gianmauro, N. The Role of microRNA in head and neck cancer: Current knowledge and perspectives. Molecules 2014, 19, 5704-5716.
11. Vicentini, C.; Fassan, M.; D'Angelo, E.; Corbo, V.; Silvestris, N.; Nuovo, G.J.; Scarpa, A. Clinical application of microRNA testing in neuroendocrine tumors of the gastrointestinal tract. Molecules 2014, 19, 2458-2468.
12. Chun, Z.; Cong, Y.; Haopeng, L.; Guoyu, W.; Xijng, H. Combined elevation of microRNA-196a and microRNA-196b in sera predicts unfavorable prognosis in patients with osteosarcomas. Int. J. Mol. Sci. 2014, 15, 6544-6555.
13. Dettmer, M.S.; Perren, A.; Moch, H.; Komminoth, P.; Nikiforov Y.E.; Nikiforova, M.N. MicroRNA profile of poorly differentiated thyroid carcinomas: New diagnostic and prognostic insights. J. Mol. Endocrinol. 2014, 52, 181-189.
14. Wojtas, B.; Ferraz, C.; Stokowy, T.; Hauptmann, S.; Lange, D.; Dralle, H.; Musholt, T.; Jarzab, B.; Paschke, R.; Eszlinger, M. Differential miRNA expression defines migration and reduced apoptosis in follicular thyroid carcinomas. Mol. Cell. Endocrinol. 2014, 388, 1-9.
15. Lundstrom, K. Micro-RNA in disease and gene therapy. Curr. Drug Discov. Technol. 2011, 8, 76-86.
16. Chou, C.K.; Yang, K.D.; Chou, F.F.; Huang, C.C.; Lan, Y.W.; Lee, Y.F.; Kang, H.Y.; Liu, R.T. Prognostic implications of miR-146b expression and its functional role in papillary thyroid carcinoma. J. Clin. Endocrinol. MeTable 2013, 98, E196-E205.
17. Yu, S.; Liu, Y.; Wang, J.; Guo, Z.; Zhang, Q.; Yu, F.; Zhang, Y.; Huang, K.; Li, Y.; Song, E.; et al. Circulating microRNA profiles as potential biomarkers for diagnosis of papillary thyroid carcinoma. J. Clin. Endocrinol. MeTable 2012, 97, 2084-2092.
18. He, H.; Jazdzewski, K.; Li, W.; Liyanarachchi, S.; Nagy, R.; Volinia, S.; Calin, G.A.; Liu, C.G.; Franssila, K.; Suster, S.; et al. The role of microRNA genes in papillary thyroid carcinoma. Proc. Natl. Acad. Sci. USA 2005, 102, 19075-19080.
19. Edge, S.B.; Compton, C.C. The American Joint Committee on Cancer: The 7th Edition of the AJCC cancer staging manual and the future of TNM. Ann. Surg. Oncol. 2010, 17, 1471-1474.
20. Pallante, P.; Visone, R.; Ferracin, M.; Ferraro, A.; Berlingieri, M.T.; Troncone, G.; Chiappetta, G.; Liu, C.G.; Santoro, M.; Negrini, M.; et al. MicroRNA deregulation in human thyroid papillary carcinomas. Endocr. Relat. Cancer. 2006, 13, 497-508.
21. Acibucu, F.; Dökmetaş, H.S.; Tutar, Y.; Elagoz, S.; Kilicli, F. Correlations between the expression levels of Micro-RNA146b, 221, 222 and p27Kip1 protein mRNA and the clinicopathologic parameters in papillary thyroid cancers. Exp. Clin. Endocrinol. Diabetes 2014, 122, 137-143.
22. Yang, Z.; Yuan, Z.; Fan, Y.; Deng, X.; Zheng, Q. Integrated analyses of microRNA and mRNA expression profiles in aggressive papillary thyroid carcinoma. Mol. Med. Rep. 2013, 8, 1353-1358
23. Lee, J.C.; Zhao, J.T.; Clifton-Bligh, R.J.; Gill, A.; Gundara, J.S.; Ip, J.C.; Glover, A.; Sywak, M.S.; Delbridge, L.W.; Robinson, B.G.; et al. MicroRNA-222 and microRNA-146b are tissue and circulating biomarkers of recurrent papillary thyroid cancer. Cancer 2013, 119, 4358-4365.
24. Wang, Z.; Zhang, H.; He, L.; Dong, W.; Li, J.; Shan, Z.; Teng, W. Association between the expression of four upregulated miRNAs and extrathyroidal invasion in papillary thyroid carcinoma. Onco Targets Ther. 2013, 6, 281-287.
25. Lloyd, R.V.; Buehler, D.; Khanafshar, E. Papillary thyroid carcinoma variants. Head Neck Pathol. 2011, 5, 51-56.
26. Rossing, M.; Borup, R.; Henao, R.; Winther, O.; Vikesaa, J.; Niazi, O.; Godballe, C.; Krogdahl, A.; Glud, M.; Hjort-Sørensen, C.; et al. Down-regulation of microRNAs controlling tumourigenic factors in follicular thyroid carcinoma. J. Mol. Endocrinol. 2012, 48, 11-23.
27. Nikiforova, M.N.; Tseng, G.C.; Steward, D.; Diorio, D.; Nikiforov, Y.E. MicroRNA expression profiling of thyroid tumors: Biological significance and diagnostic utility. J. Clin. Endocrinol. MeTable 2008, 93, 1600-1608.
28. Zhang, J.; Liu, Y.; Liu, Z.; Wang, X.M.; Yin, D.T.; Zheng, L.L.; Zhang, D.Y.; Lu, X.B. Differential expression profiling and functional analysis of microRNAs through stage I-III papillary thyroid carcinoma. Int. J. Med. Sci. 2013, 10, 585-592.
29. Liu, X.; He, M.; Hou, Y.; Liang, B.; Zhao, L.; Ma, S.; Yu, Y.; Liu, X. Expression profiles of microRNAs and their target genes in papillary thyroid carcinoma. Oncol. Rep. 2013, 29, 1415-1420.
30. Yip, L.; Kelly, L.; Shuai, Y.; Armstrong, M.J.; Nikiforov, Y.E.; Carty, S.E.; Nikiforova, M.N. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann. Surg. Oncol. 2011, 18, 2035-2041.
31. Chou, C.K.; Chen, R.F.; Chou, F.F.; Chang, H.W.; Chen, Y.J.; Lee, Y.F.; Yang, K.D.; Cheng, J.T.; Huang, C.C.; Liu, R.T. miR-146b is highly expressed in adult papillary thyroid carcinomas with high risk features including extrathyroidal invasion and the BRAF(V600E) mutation. Thyroid 2010, 20, 489-494.
32. Natali, P.G.; Berlingieri, M.T.; Nicotra, M.R.; Fusco, A.; Santoro, E.; Bigotti, A.; Vecchio, G. Transformation of thyroid epithelium is associated with loss of c-kit receptor. Cancer Res. 1995, 55, 1787-1791.
33. Hurst, D.R.; Edmonds, M.D.; Scott, G.K.; Benz, C.C.; Vaidya, K.S.; Welch, D.R. Breast cancer metastasis suppressor 1 up-regulates miR-146, which suppresses breast cancer metastasis. Cancer Res. 2009, 69, 1279-1283.
34. Katakowski, M.; Zheng, X.; Jiang, F.; Rogers, T.; Szalad, A.; Chopp, M. MiR-146b-5p suppresses EGFR expression and reduces in vitro migration and invasion of glioma. Cancer Investig. 2010, 28, 1024-1030.
35. Braun, J.; Hoang-Vu, C.; Dralle, H.; Hüttelmaier, S. Downregulation of microRNAs directs the EMT and invasive potential of anaplastic thyroid carcinomas. Oncogene 2010, 29, 4237-4244.
36. Wang, C.; Song, B.; Song, W.; Liu, J.; Sun, A.; Wu, D.; Yu, H.; Lian, J.; Chen, L.; Han, J. Underexpressed microRNA-199b-5p targets hypoxia-inducible factor-1α in hepatocellular carcinoma and predicts prognosis of hepatocellular carcinoma patients. J. Gastroenterol. Hepatol. 2011, 26, 1630-1637.
37. Flamant, S.; Ritchie, W.; Guilhot, J.; Holst, J.; Bonnet, M.L.; Chomel, J.C.; Guilhot, F.; Turhan, A.G.; Rasko, J.E. Micro-RNA response to imatinib mesylate in patients with chronic myeloid leukemia. Haematologica 2010, 95, 1325-1333.
38. Nymark, P.; Guled, M.; Borze, I.; Faisal, A.; Lahti, L.; Salmenkivi, K.; Kettunen, E.; Anttila, S.; Knuutila, S. Integrative analysis of microRNA, mRNA and aCGH data reveals asbestos- and histology-related changes in lung cancer. Gene. Chromosome. Canc. 2011, 50, 585-597.
39. The Diana Lab Homepage. Available online: http://diana.cslab.ece.ntua.gr/ (accessed on 4 August 2014).
40. miRBase: The microRNA Database. Available online: http://www.mirbase.org/ (accessed on 4 August 2014).